GPS Cancer is a proteogenomic molecular test that helps oncologists guide treatment strategies. It sequences the whole genome of more than 20,000 genes and three billion base pairs, matching against the patient’s normal DNA to help inform personalized treatment strategies.
Asia Genomics, a provider and distributor of molecular testing services in Southeast Asia, will offer the GPS Cancer tool in Singapore, Malaysia, Thailand, Vietnam and the Philippines.
More articles on data analytics & precision medicine:
Yale New Haven Health System integrates ActX Genomic Decision Support in Epic EHR
Wisconsin researchers awarded $5.3M for NIH All of Us program
Chicagoland hospital to offer genetic testing as part of an annual checkup
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
